Biological response modifiers in Ophthalmology: New horizons, new challenges and new hopes
“Biologic response modifier”(BRM) treatment refers to the treatment of human diseases with a diverse group of agents which are generated from living cells, and which act on the immune system, altering the body's immune response. The principal mechanism of action of these agents includes immunom...
Main Author: | Kaberi Biswas Feroze |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Kerala Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.kjophthal.com/article.asp?issn=0976-6677;year=2018;volume=30;issue=2;spage=76;epage=86;aulast=Feroze |
Similar Items
-
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis
by: Jashin J. Wu, et al.
Published: (2023-12-01) -
New immunological aspects of peri-implantitis
by: Bárbara Bellocchio Bertoldo, et al.
Published: (2024-03-01) -
Tumor necrosis factor antagonists: structure, function and tuberculosis risks
by: Jacyr Pasternak
Published: (2009-03-01) -
New horizons in the use of biological agents during pregnancy in patients with rheumatic disease
by: P A Shesternya, et al.
Published: (2017-05-01) -
Research progress of anti-neovascularization drugs in the relationship between ophthalmology and oncology
by: Shuang Zhang<sup>*</sup>, et al.
Published: (2020-10-01)